Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension
- PMID: 22955318
- DOI: 10.1164/rccm.201202-0335OC
Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension
Abstract
Rationale: Pulmonary arterial hypertension (PAH) is characterized by vasoconstriction and vascular remodeling. Recent studies have revealed that immune and inflammatory responses play a crucial role in pathogenesis of idiopathic PAH.
Objectives: To systematically evaluate the number and cross-sectional distribution of inflammatory cells in different sizes of pulmonary arteries from explanted lungs of patients with idiopathic PAH versus healthy donor lungs and to demonstrate functional relevance by blocking stromal-derived factor-1 by the Spiegelmer NOX-A12 in monocrotaline-induced pulmonary hypertension in rats.
Methods: Immunohistochemistry was performed on lung tissue sections from patients with idiopathic PAH and healthy donors. All positively stained cells in whole-lung tissue sections, surrounding the vessels, and in the different compartments of the vessels were counted. To study the effects of blocking SDF-1, rats with monocrotaline-induced pulmonary hypertension were treated with NOX-A12 from Day 21 to Day 35 after monocrotaline administration.
Measurements and main results: We found a significant increase of the perivascular number of macrophages (CD68(+)), macrophages/monocytes (CD14(+)), mast cells (toluidine blue(+)), dendritic cells (CD209(+)), T cells (CD3(+)), cytotoxic T cells (CD8(+)), and helper T cells (CD4(+)) in vessels of idiopathic PAH lungs compared with control subjects. FoxP3(+) mononuclear cells were significantly decreased. In the monocrotaline model, the NOX-A12-induced reduction of mast cells, CD68(+) macrophages, and CD3(+) T cells was associated with improvement of hemodynamics and pulmonary vascular remodeling.
Conclusions: Our findings reveal altered perivascular inflammatory cell infiltration in pulmonary vascular lesions of patients with idiopathic pulmonary arterial hypertension. Targeting attraction of inflammatory cells by blocking stromal-derived factor-1 may be a novel approach for treatment of PAH.
Similar articles
-
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.Circulation. 2007 May 1;115(17):2331-9. doi: 10.1161/CIRCULATIONAHA.106.676809. Epub 2007 Apr 16. Circulation. 2007. PMID: 17438150
-
Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.Ann Thorac Surg. 2009 Aug;88(2):418-24. doi: 10.1016/j.athoracsur.2009.04.105. Ann Thorac Surg. 2009. PMID: 19632386
-
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension.Eur Respir J. 2007 Mar;29(3):462-8. doi: 10.1183/09031936.00094706. Epub 2006 Nov 15. Eur Respir J. 2007. PMID: 17107989
-
Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.Compr Physiol. 2011 Oct;1(4):1929-41. doi: 10.1002/cphy.c100028. Compr Physiol. 2011. PMID: 23733693 Review.
-
Anti-inflammatory and immunosuppressive agents in PAH.Handb Exp Pharmacol. 2013;218:437-76. doi: 10.1007/978-3-642-38664-0_18. Handb Exp Pharmacol. 2013. PMID: 24092351 Review.
Cited by
-
Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis.Hypertension. 2020 Sep;76(3):985-996. doi: 10.1161/HYPERTENSIONAHA.120.14697. Epub 2020 Jul 27. Hypertension. 2020. PMID: 32713273 Free PMC article.
-
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management.Int J Mol Sci. 2024 Aug 1;25(15):8427. doi: 10.3390/ijms25158427. Int J Mol Sci. 2024. PMID: 39125996 Free PMC article. Review.
-
Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1/STAT3 signaling pathway.J Ginseng Res. 2024 Jul;48(4):405-416. doi: 10.1016/j.jgr.2024.03.001. Epub 2024 Mar 11. J Ginseng Res. 2024. PMID: 39036731 Free PMC article.
-
Endothelial Basement Membrane Components and Their Products, Matrikines: Active Drivers of Pulmonary Hypertension?Cells. 2020 Sep 3;9(9):2029. doi: 10.3390/cells9092029. Cells. 2020. PMID: 32899187 Free PMC article. Review.
-
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.Am J Respir Crit Care Med. 2022 Jul 1;206(1):81-93. doi: 10.1164/rccm.202108-1919OC. Am J Respir Crit Care Med. 2022. PMID: 35316153 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials